Surgical approaches in thyroid cancer and lymph-node metastases.
暂无分享,去创建一个
[1] Stephanie L. Lee,et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.
[2] S. Hauptmann,et al. Referral bias in thyroid cancer surgery: direction and magnitude. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[3] S. Hauptmann,et al. Prediction of lateral lymph node metastases in medullary thyroid cancer , 2008, The British journal of surgery.
[4] A. Miyauchi,et al. Risk Factors for Recurrence to the Lymph Node in Papillary Thyroid Carcinoma Patients without Preoperatively Detectable Lateral Node Metastasis: Validity of Prophylactic Modified Radical Neck Dissection , 2007, World Journal of Surgery.
[5] C. Ko,et al. Extent of Surgery Affects Survival for Papillary Thyroid Cancer , 2007, Annals of surgery.
[6] B. Caillou,et al. Poorly differentiated follicular thyroid carcinoma: prognostic factors and relevance of histological classification. , 2007, Thyroid : official journal of the American Thyroid Association.
[7] E. Lee,et al. Extent of Routine Central Lymph Node Dissection With Small Papillary Thyroid Carcinoma , 2007, World Journal of Surgery.
[8] S. Hauptmann,et al. Increased Risk of Lymph Node Metastasis in Multifocal Hereditary and Sporadic Medullary Thyroid Cancer , 2007, World Journal of Surgery.
[9] S. Hauptmann,et al. Locoregional recurrence and death from medullary thyroid carcinoma in a contemporaneous series: 5-year results. , 2007, European journal of endocrinology.
[10] B. Lang,et al. Staging Systems for Papillary Thyroid Carcinoma: A Study of 2 Tertiary Referral Centers , 2007, Annals of surgery.
[11] J. Furlan,et al. Significance of Tumor Capsular Invasion in Well-Differentiated Thyroid Carcinomas , 2007, The American surgeon.
[12] H. Dralle. Evidence-Based Endocrine Surgery: Thyroid Cancer , 2007, World Journal of Surgery.
[13] J. Moley,et al. Evidence-based Approach to the Management of Sporadic Medullary Thyroid Carcinoma , 2007, World Journal of Surgery.
[14] J. Roh,et al. Total Thyroidectomy Plus Neck Dissection in Differentiated Papillary Thyroid Carcinoma Patients: Pattern of Nodal Metastasis, Morbidity, Recurrence, and Postoperative Levels of Serum Parathyroid Hormone , 2007, Annals of surgery.
[15] G. Doherty,et al. Central Lymph Node Dissection in Differentiated Thyroid Cancer , 2007, World Journal of Surgery.
[16] B. Lang,et al. Surgical Options in Undifferentiated Thyroid Carcinoma , 2007, World journal of surgery.
[17] A. Miyauchi,et al. Lateral and Mediastinal Lymph Node Dissection in Differentiated Thyroid Carcinoma: Indications, Benefits, and Risks , 2007, World Journal of Surgery.
[18] G. Cote,et al. Multiple Endocrine Neoplasia Type 2 , 2006 .
[19] S. Sidhu,et al. Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. , 2006, Surgery.
[20] Yasuhiro Ito,et al. Clinical Significance of Lymph Node Metastasis of Thyroid Papillary Carcinoma Located in One Lobe , 2006, World Journal of Surgery.
[21] W. Wiersinga,et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. , 2006, European journal of endocrinology.
[22] Louise Davies,et al. Increasing incidence of thyroid cancer in the United States, 1973-2002. , 2006, JAMA.
[23] J. Shah,et al. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis , 2006, Cancer.
[24] Gerard M Doherty,et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2006, Thyroid : official journal of the American Thyroid Association.
[25] R. Wahl,et al. Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study. , 2006, The Journal of clinical endocrinology and metabolism.
[26] K. Schmid,et al. How to define follicular thyroid carcinoma? , 2006, Virchows Archiv.
[27] A. Lam,et al. Diffuse Sclerosing Variant of Papillary Carcinoma of the Thyroid: A 35-Year Comparative Study at a Single Institution , 2006, Annals of surgical oncology.
[28] J. Jimeno,et al. Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. , 2005, Surgery.
[29] D. Urbach,et al. The treatment and prognosis of Hürthle cell follicular thyroid carcinoma compared with its non-Hürthle cell counterpart. , 2005, Surgery.
[30] K. Lam,et al. Follicular Thyroid Carcinoma: The Role of Histology and Staging Systems in Predicting Survival , 2005, Annals of surgery.
[31] E. Baudin,et al. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. , 2005, The Journal of clinical endocrinology and metabolism.
[32] K. Owzar,et al. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. , 2005, The New England journal of medicine.
[33] Guojun Wu,et al. High prevalence and possible de novo formation of BRAF mutation in metastasized papillary thyroid cancer in lymph nodes. , 2005, The Journal of clinical endocrinology and metabolism.
[34] A. Miyauchi,et al. Papillary Microcarcinomas of the Thyroid with Preoperatively Detectable Lymph Node Metastasis Show Significantly Higher Aggressive Characteristics on Immunohistochemical Examination , 2005, Oncology.
[35] A. Miyauchi,et al. Ultrasonographically and Anatomopathologically Detectable Node Metastases in the Lateral Compartment as Indicators of Worse Relapse-free Survival in Patients with Papillary Thyroid Carcinoma , 2005, World Journal of Surgery.
[36] M. Hočevar,et al. Is patient's age a prognostic factor for follicular thyroid carcinoma in the TNM classification system? , 2005, Thyroid : official journal of the American Thyroid Association.
[37] E. Kebebew,et al. Extent of disease and practice patterns for medullary thyroid cancer. , 2005, Journal of the American College of Surgeons.
[38] E. Baudin,et al. Follicular Cell-Derived Thyroid Cancer in Children , 2005, Hormone Research in Paediatrics.
[39] H. Holzhausen,et al. Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level. , 2005, The Journal of clinical endocrinology and metabolism.
[40] E. Kebebew,et al. Anaplastic thyroid carcinoma , 2005, Cancer.
[41] K. Kaczirek,et al. Importance of tumour size in papillary and follicular thyroid cancer , 2005, The British journal of surgery.
[42] H. Dralle,et al. Advances in the management of hereditary medullary thyroid cancer , 2005, Journal of internal medicine.
[43] Jeffrey E. Lee,et al. Preventable reoperations for persistent and recurrent papillary thyroid carcinoma. , 2004, Surgery.
[44] Phuong Nguyen Thanh,et al. Timing and Extent of Surgery in Patients with Familial Medullary Thyroid Carcinoma/Multiple Endocrine Neoplasia 2A-related RET Mutations Not Affecting Codon 634 , 2004, World Journal of Surgery.
[45] A. Goropoulos,et al. Value of the Cervical Compartments in the Surgical Treatment of Papillary Thyroid Carcinoma , 2004, World Journal of Surgery.
[46] A. Miyauchi,et al. Papillary Microcarcinoma of the Thyroid: How Should It Be Treated? , 2004, World Journal of Surgery.
[47] H. Holzhausen,et al. Prediction of mediastinal lymph node metastasis in medullary thyroid carcinoma , 2004, The British journal of surgery.
[48] A. Miyauchi,et al. Preoperative Ultrasonographic Examination for Lymph Node Metastasis: Usefulness when Designing Lymph Node Dissection for Papillary Microcarcinoma of the Thyroid , 2004, World Journal of Surgery.
[49] Q. Duh,et al. Follicular thyroid carcinoma: Histology and prognosis , 2004, Cancer.
[50] K. Kaczirek,et al. Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region. , 2004, Endocrine-related cancer.
[51] J. Furlan,et al. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas. , 2004, Journal of the American College of Surgeons.
[52] I. Sugitani,et al. A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. , 2004, Surgery.
[53] H. Dralle,et al. Early malignant progression of hereditary medullary thyroid cancer. , 2003, The New England journal of medicine.
[54] H. Holzhausen,et al. Enhancement of lymph node metastasis and distant metastasis of thyroid carcinoma , 2003, Cancer.
[55] E. Baudin,et al. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. , 2003, The Journal of clinical endocrinology and metabolism.
[56] Jeffrey E. Lee,et al. Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship. , 2003, Archives of surgery.
[57] Koichi Ito,et al. Lymph Node Metastasis From 259 Papillary Thyroid Microcarcinomas: Frequency, Pattern of Occurrence and Recurrence, and Optimal Strategy for Neck Dissection , 2003, Annals of surgery.
[58] A. Belfiore,et al. Long‐term outcome of patients with insular carcinoma of the thyroid , 2002, Cancer.
[59] B. Barraclough,et al. Minimally invasive follicular thyroid carcinoma: Completion thyroidectomy or not? , 2002, ANZ journal of surgery.
[60] W. Mendenhall,et al. Follicular thyroid carcinoma , 2002, Cancer.
[61] P. Levine,et al. Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. , 2002, Archives of otolaryngology--head & neck surgery.
[62] H. Röher,et al. Importance of Lymph Node Metastases in Follicular Thyroid Cancer , 2002, World Journal of Surgery.
[63] Q. Duh,et al. Complications of Neck Dissection for Thyroid Cancer , 2002, World Journal of Surgery.
[64] S. Takao,et al. Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma. , 2002, Surgery.
[65] John P. Bilezikian,et al. CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2 , 2001 .
[66] C. Sekulla,et al. Analysis of Surgery‐Related Complications in Thyroid Carcinoma – A German Prospective Multicentre Study with 275 Patients , 2001 .
[67] V. Rohmer,et al. Familial medullary thyroid carcinoma with noncysteine ret mutations: phenotype-genotype relationship in a large series of patients. , 2001, The Journal of clinical endocrinology and metabolism.
[68] R. Hinze,et al. Multivariate analysis of clinicopathologic parameters for the insular subtype of differentiated thyroid carcinoma. , 2001, Archives of surgery.
[69] C. Esselstyn,et al. Conservative management of patients with intrathyroidal well-differentiated follicular thyroid carcinoma. , 2001, Surgery.
[70] A. Shaha. Invited commentary: Minimally invasive follicular thyroid carcinoma. , 2001, Surgery.
[71] R. Hinze,et al. Importance of Early Screening and Prophylactic Thyroidectomy in Asymptomatic Nonindex RET Germline Carriers , 2001, World Journal of Surgery.
[72] R. Hinze,et al. Extended surgery and early postoperative radiotherapy for undifferentiated thyroid carcinoma. , 2001, Thyroid : official journal of the American Thyroid Association.
[73] M. Schlumberger,et al. Papillary and follicular thyroid carcinoma. , 2000, Bailliere's best practice & research. Clinical endocrinology & metabolism.
[74] R. Hinze,et al. Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysis , 2000, Cancer.
[75] C. Reiners,et al. Is the UICC/AJCC classification of primary tumor in childhood thyroid carcinoma valid? , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[76] H. Dralle,et al. Repeat mediastinal lymph-node dissection for palliation in advanced medullary thyroid carcinoma , 1999, Langenbeck's Archives of Surgery.
[77] M. Silverman,et al. Follicular and Hürthle cell carcinoma: predicting outcome and directing therapy. , 1998, Surgery.
[78] D. Carter. TNM Classification of Malignant Tumors , 1998 .
[79] R. Hinze,et al. Prophylactic Thyroidectomy in 75 Children and Adolescents with Hereditary Medullary Thyroid Carcinoma: German and Austrian Experience , 1998, World Journal of Surgery.
[80] D. Ball,et al. Effective long-term palliation of symptomatic, incurable metastatic medullary thyroid cancer by operative resection. , 1998, Annals of surgery.
[81] H. Dralle,et al. Determinative Factors of Biochemical Cure after Primary and Reoperative Surgery for Sporadic Medullary Thyroid Carcinoma , 1998, World Journal of Surgery.
[82] T. Defechereux,et al. Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinoma , 1998, Langenbeck's Archives of Surgery.
[83] M. Schlumberger,et al. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients , 1998 .
[84] H. Dralle,et al. Reoperation in metastasizing medullary thyroid carcinoma: is a tumor stage-oriented approach justified? , 1997, Surgery.
[85] H. Dralle,et al. Lymphadenektomie beim Schilddrüsencarcinom , 1996, Der Chirurg.
[86] V. Deshmane,et al. Prognostic factors in follicular carcinoma of the thyroid: A study of 198 cases , 1996, Head & neck.
[87] J. Shah,et al. Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. , 1995, Surgery.
[88] E. Germann,et al. An evaluation of prognostic scoring systems in patients with follicular thyroid cancer. , 1995, American journal of surgery.
[89] H. Dralle,et al. The value of lymph node dissection in hereditary medullary thyroid carcinoma: a retrospective, European, multicentre study , 1995, Journal of internal medicine.
[90] E. Kaplan,et al. Morbidity and mortality in follicular thyroid cancer. , 1995, The Journal of clinical endocrinology and metabolism.
[91] J. Shah,et al. Intermediate-risk group for differentiated carcinoma of thyroid. , 1994, Surgery.
[92] H. Hundeshagen,et al. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer , 1994, World Journal of Surgery.
[93] J. Moley,et al. Reoperation for recurrent or persistent medullary thyroid cancer. , 1993, Surgery.
[94] A. Sugenoya,et al. Clinical evaluation of upper mediastinal dissection for differentiated thyroid carcinoma. , 1993, Surgery.
[95] E. Bergstralh,et al. Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy. , 1992, Surgery.
[96] J E Medina,et al. Standardizing neck dissection terminology. Official report of the Academy's Committee for Head and Neck Surgery and Oncology. , 1991, Archives of otolaryngology--head & neck surgery.
[97] B. Cady,et al. An expanded view of risk-group definition in differentiated thyroid carcinoma. , 1988, Surgery.
[98] L. Woolner,et al. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. , 1986, Mayo Clinic proceedings.
[99] G. Laramore,et al. Shoulder pain and function after neck dissection with or without preservation of the spinal accessory nerve. , 1984, American journal of surgery.
[100] C R Feind,et al. Contralateral spread of head and neck cncer. , 1969, American journal of surgery.
[101] Su He Wang,et al. No apparent damage in the thyroid of transgenic mice expressing antiapoptotic FLIP. , 2006, Thyroid : official journal of the American Thyroid Association.
[102] H. Dralle,et al. Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma , 2006, Surgery Today.
[103] H. Holzhausen,et al. Contralateral cervical and mediastinal lymph node metastasis in medullary thyroid cancer: systemic disease? , 2006, Surgery.
[104] A. Miyauchi,et al. Clinical Significance of Metastasis to the Central Compartment from Papillary Microcarcinoma of the Thyroid , 2005, World Journal of Surgery.
[105] A. Pinchera,et al. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. , 2004, The Journal of clinical endocrinology and metabolism.
[106] H. Dralle,et al. Die transsternale zervikomediastinale Primärtumorresektion und Lymphadenektomie beim Schilddrüsenkarzinom , 2004, Langenbecks Archiv für Chirurgie.
[107] E. Berg,et al. World Health Organization Classification of Tumours , 2002 .
[108] R. Hinze,et al. Pattern of Nodal Metastasis for Primary and Reoperative Thyroid Cancer , 2002, World journal of surgery.
[109] R. Hinze,et al. Thyroid carcinoma invading the cervicovisceral axis: routes of invasion and clinical implications. , 2001, Surgery.
[110] M. Tötsch,et al. Minimally invasive follicular thyroid carcinoma: a clinico-pathological study. , 1997, Current topics in pathology. Ergebnisse der Pathologie.
[111] P. Ladenson,et al. Optimal Surgery for Papillary Thyroid Carcinoma , 1996, World Journal of Surgery.